SpecGX LLC
21Patents
21Active
21Granted
50Portfolio score
Filing activity: Apr 18, 2013 → Nov 8, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10441508B2 | Systems and methods for high humidity curing within tablet coating system | Performing Operations; Transporting | 2 | Active |
| US10227335B2 | Preparation of sufentanil citrate and sufentanil base | Chemistry; Metallurgy | 2 | Active |
| US10624888B2 | Extended release, abuse deterrent dosage forms | Human Necessities | 2 | Active |
| US11033508B2 | Delayed sustained release pharmaceutical compositions | Human Necessities | 1 | Active |
| US11077024B2 | Systems and methods for high humidity curing within tablet coating system | Performing Operations; Transporting | 1 | Active |
| US9993422B2 | Immediate release, abuse deterrent pharmaceutical compositions | Human Necessities | 1 | Active |
| US10485753B2 | Extended release, abuse deterrent pharmaceutical compositions | Human Necessities | 0 | Active |
| US11617712B2 | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides | Human Necessities | 0 | Active |
| US11065246B2 | Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties | Human Necessities | 0 | Active |
| US10927068B2 | Process for preparing acylated amphetamine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US11446293B2 | Extended release, abuse deterrent dosage forms | Human Necessities | 0 | Active |
| US11464741B2 | Spray dried compositions having different dissolution profiles and processes for their preparation | Human Necessities | 0 | Active |
| US11478426B2 | Abuse deterrent immediate release capsule dosage forms | Human Necessities | 0 | Active |
| US11583493B2 | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides | Human Necessities | 0 | Active |
| US11517521B2 | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides | Human Necessities | 0 | Active |
| US12208094B2 | Extended release, abuse deterrent dosage forms | Human Necessities | 0 | Active |
| US11666509B2 | Systems and methods for high humidity curing within tablet coating system | Performing Operations; Transporting | 0 | Active |
| US11096887B2 | Extended release, abuse deterrent pharmaceutical compositions | Human Necessities | 0 | Active |
| US12371423B2 | Preparation of sufentanil citrate and sufentanil base | Chemistry; Metallurgy | 0 | Active |
| US10899749B2 | Preparation of sufentanil citrate and sufentanil base | Chemistry; Metallurgy | 0 | Active |
| US10089678B1 | Suspicious order monitoring system and method | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.